1010096-65-7

LY2183240 is a potent, competitive small molecule inhibitor of anandamide uptake (IC₅₀ = 270 pM; K_i = 540 pM) and hydrolysis. It has been shown to increase anandamide levels in rat cerebellum (ED₅₀ = 1.37 mg/kg) and displays dose-dependent efficacy (3-30 mg/kg) in several rodent models of persistent pain. LY2183240 2’-isomer is a less potent, 2,5-regioisomer of LY2183240 that inhibits anandamide hydrolysis and uptake with IC₅₀ values of 33 and 998 nM, respectively.

5-([1,1''-Biphenyl]-4-ylmethyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide is an inhibitor of human monoacylglycerol lipase (hMGL).

Store at -20°C